» Articles » PMID: 32660156

The Adipokines in Cancer Cachexia

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Jul 15
PMID 32660156
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Cachexia is a devastating pathology induced by several kinds of diseases, including cancer. The hallmark of cancer cachexia is an extended weight loss mainly due to skeletal muscle wasting and fat storage depletion from adipose tissue. The latter exerts key functions for the health of the whole organism, also through the secretion of several adipokines. These hormones induce a plethora of effects in target tissues, ranging from metabolic to differentiating ones. Conversely, the decrease of the circulating level of several adipokines positively correlates with insulin resistance, metabolic syndrome, diabetes, and cardiovascular disease. A lot of findings suggest that cancer cachexia is associated with changed secretion of adipokines by adipose tissue. In agreement, cachectic patients show often altered circulating levels of adipokines. This review reported the findings of adipokines (leptin, adiponectin, resistin, apelin, and visfatin) in cancer cachexia, highlighting that to study in-depth the involvement of these hormones in this pathology could lead to the development of new therapeutic strategies.

Citing Articles

Impact of exercise on cancer: mechanistic perspectives and new insights.

Feng Y, Feng X, Wan R, Luo Z, Qu L, Wang Q Front Immunol. 2024; 15:1474770.

PMID: 39346906 PMC: 11427289. DOI: 10.3389/fimmu.2024.1474770.


Research progress on the role of adipocyte exosomes in cancer progression.

Wang Y, Li X, Liu D, Wang Z, Xia J, Wang L Oncol Res. 2024; 32(10):1649-1660.

PMID: 39308520 PMC: 11413817. DOI: 10.32604/or.2024.043482.


Adiponectin as a predictor of mortality and readmission in patients with community-acquired pneumonia: a prospective cohort study.

Matovu Dungu A, Ryrso C, Hegelund M, Sejdic A, Jensen A, Kristensen P Front Med (Lausanne). 2024; 11:1329417.

PMID: 38633314 PMC: 11022597. DOI: 10.3389/fmed.2024.1329417.


extract and xanthorrhizol ameliorate cancer-induced adipose wasting in CT26-bearing mice by regulating lipid metabolism and adipose tissue browning.

Kim H, Lee D, Hwang J Integr Med Res. 2024; 13(1):101020.

PMID: 38298864 PMC: 10826318. DOI: 10.1016/j.imr.2023.101020.


Toward a holistic understanding of cancer cachexia: Application of the human response to illness model.

McClement S Asia Pac J Oncol Nurs. 2024; 10(Suppl 1):100306.

PMID: 38197036 PMC: 10772185. DOI: 10.1016/j.apjon.2023.100306.


References
1.
Gulen S, Karadag F, Karul A, Kilicarslan N, Ceylan E, Kuman N . Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung. 2012; 190(3):327-32. DOI: 10.1007/s00408-011-9364-6. View

2.
Di Zazzo E, Polito R, Bartollino S, Nigro E, Porcile C, Bianco A . Adiponectin as Link Factor between Adipose Tissue and Cancer. Int J Mol Sci. 2019; 20(4). PMC: 6412253. DOI: 10.3390/ijms20040839. View

3.
Chandran M, Phillips S, Ciaraldi T, Henry R . Adiponectin: more than just another fat cell hormone?. Diabetes Care. 2003; 26(8):2442-50. DOI: 10.2337/diacare.26.8.2442. View

4.
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

5.
Kir S, White J, Kleiner S, Kazak L, Cohen P, Baracos V . Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014; 513(7516):100-4. PMC: 4224962. DOI: 10.1038/nature13528. View